Astrana Health, Inc. (ASTH) Financial Statements
Astrana Health, Inc. (ASTH) reported trailing twelve-month revenue of $3.8B (up 58.9% year on year) and net income of $40.5M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $94.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ASTHAstrana Health, Inc.Follow ASTH — free
—
Price chart with a free account
- Market cap
- 2.1B
- P/E TTM
- 45.1
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2012 Jan 12 | FY2013 Jan 13 | FY2014 Jan 14 | FY2015 Mar 15 | FY2016 Mar 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.01 | 0.01 | 0.01 | 0.03 | 0.04 | 0.36 | 0.52 | 0.56 | 0.69 | 0.77 | 1.14 | 1.39 | 2.03 | 3.18 | 3.84 | |
| Gross profit | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.08 | 0.16 | 0.09 | 0.15 | 0.18 | 0.20 | 0.21 | 0.27 | 0.34 | 0.40 | |
| Operating income | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | 0.04 | 0.09 | 0.03 | 0.08 | 0.10 | 0.10 | 0.08 | 0.09 | 0.08 | 0.10 | |
| Pre-tax income | -0.00 | -0.01 | -0.00 | -0.00 | -0.01 | 0.05 | 0.08 | 0.03 | 0.18 | 0.08 | 0.09 | 0.09 | 0.08 | 0.04 | 0.06 | |
| Income tax | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.02 | 0.01 | 0.06 | 0.03 | 0.04 | 0.03 | 0.03 | 0.02 | 0.02 | |
| Net income | -0.00 | -0.01 | -0.01 | -0.00 | -0.01 | 0.03 | 0.01 | 0.01 | 0.04 | 0.07 | 0.05 | 0.06 | 0.04 | 0.02 | 0.04 | |
| Diluted EPS ($) | -0.02 | -0.27 | -1.37 | -0.37 | -1.79 | 0.90 | 0.29 | 0.39 | 1.01 | 1.52 | 0.99 | 1.29 | 0.90 | 0.46 | 0.83 | |
| Diluted shares (bn) | — | — | — | — | — | 0.029 | 0.038 | 0.036 | 0.037 | 0.045 | 0.046 | 0.047 | 0.048 | 0.049 | — |
USD billions · SEC XBRL
Astrana Health, Inc. — questions
- What is Astrana Health, Inc.'s revenue?
- $3.8B over the twelve months to 2026-06-30, up 58.9% year on year, from its 10-Q and 10-K filings.
- What is Astrana Health, Inc.'s net income?
- $40.5M over the twelve months to 2026-06-30.
- What is Astrana Health, Inc.'s free cash flow?
- $94.4M over the twelve months to 2026-06-30.
- What are Astrana Health, Inc.'s diluted earnings per share?
- $0.83 over the twelve months to 2026-06-30.
Every figure on this page comes from Astrana Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.